On Invalid Date, Neuronetics (NASDAQ: STIM) reported Q3 2023 earnings per share (EPS) of -$0.33, up 17.86% year over year. Total Neuronetics earnings for the quarter were -$9.39 million. In the same quarter last year, Neuronetics's earnings per share (EPS) was -$0.28.
As of Q4 2023, Neuronetics's earnings has grown year over year. Neuronetics's earnings in the past year totalled -$33.10 million.
What was STIM's revenue last quarter?
On Invalid Date, Neuronetics (NASDAQ: STIM) reported Q3 2023 revenue of $17.88 million up 8.4% year over year. In the same quarter last year, Neuronetics's revenue was $16.50 million.
What was STIM's revenue growth in the past year?
As of Q4 2023, Neuronetics's revenue has grown 11.61% year over year. This is 11.02 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.6%. Neuronetics's revenue in the past year totalled $69.23 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.